Skip to main content

Table 3 Odds ratios from multinomial logistic regression models for CKD stage 3 and stages 4–5 per μm increase in thickness of the full retina, inner retina and outer retina

From: Association of reduced inner retinal thicknesses with chronic kidney disease

ETDRS segmentRight eyeLeft eye
CKD stage 3 (vs. stage 1–2)CKD stage 4–5 (vs. stage 1–2)CKD stage 3 (vs. stage 1–2)CKD stage 4–5 (vs. stage 1–2)
OR95% CIpOR95% CIpOR95% CIpOR95% CIp
Full retinal thickness
 N11.00(0.97, 1.02)0.890.97(0.94, 0.99)0.02*1.00(0.98, 1.01)0.700.98(0.95, 1.00)0.03*
 S11.00(0.98, 1.03)0.760.97(0.94, 0.99)0.01*1.00(0.98, 1.01)0.690.97(0.95, 0.99)0.01*
 T11.00(0.98, 1.02)0.800.99(0.97, 1.01)0.331.00(0.98, 1.02)0.830.98(0.96, 1.00)0.08
 I11.00(0.97, 1.02)0.870.97(0.95, 1.00)0.02*1.00(0.98, 1.01)0.730.97(0.94, 0.99)0.01*
Inner Retinal Layer
 N11.00(0.97, 1.02)0.700.97(0.94, 0.99)0.01*0.99(0.97, 1.01)0.320.98(0.95, 1.00)0.03*
 S11.00(0.98, 1.03)0.870.97(0.94, 0.99)0.01*0.99(0.98, 1.01)0.470.97(0.95, 0.99)0.01*
 T11.00(0.98, 1.02)0.920.99(0.96, 1.01)0.341.00(0.98, 1.01)0.710.98(0.96, 1.00)0.09
 I11.00(0.97, 1.02)0.800.97(0.94, 0.99)0.02*0.99(0.97, 1.01)0.470.97(0.94, 0.99)0.01*
Outer Retinal Layer
 N11.08(0.96, 1.22)0.221.01(0.86, 1.18)0.931.12(0.99, 1.28)0.081.00(0.85, 1.17)0.96
 S11.07(0.93, 1.22)0.341.00(0.84, 1.18)0.961.08(0.96, 1.21)0.200.97(0.83, 1.13)0.68
 T11.10(0.96, 1.25)0.191.01(0.84, 1.20)0.941.08(0.93, 1.26)0.310.99(0.82, 1.18)0.90
 I11.05(0.92, 1.21)0.461.05(0.89, 1.25)0.541.09(0.96, 1.23)0.181.02(0.88, 1.18)0.82
  1. ETDRS Early Treatment Diabetic Retinopathy Study, OR Odds ratio, SD Standard deviation, CI Confidence interval, F Fovea, S1 Superior segment 1, N1 Nasal segment 1, I1 Inferior segment 1, T1 Temporal segment 1.*significant values. Adjustment for age, mean arterial blood pressure, diabetes status, low-density lipoprotein, body mass index, and sex